GILD analyst estimates

Gilead (GILD) analyst ratings, the average price target and its range, and every firm's latest call.

GILD analyst ratings and price targets

DateFirmCallTarget
Nov 18, 2026TD CowenTD Cowen Reiterates Buy Rating on Gilead Sciences (GILD)$175.00
Nov 12, 2026Argus ResearchGilead Sciences (GILD) PT Raised to $190 at Argus$190.00
Nov 4, 2026JefferiesJefferies Reiterates Buy Rating on Gilead Sciences (GILD)$196.00
Nov 2, 2026BernsteinGilead Sciences (GILD) PT Raised to $175 at Bernstein SocGen Group$175.00
Oct 30, 2026BMO CapitalGilead Sciences (GILD) PT Raised to $184 at BMO Capital$184.00
Oct 30, 2026NeedhamGilead Sciences (GILD) PT Raised to $175 at TD Cowen$175.00
Oct 30, 2026UBSGilead Sciences (GILD) PT Raised to $195 at UBS on Revenue Beat, Raised Guidance$195.00
Oct 23, 2026JefferiesGilead Sciences (GILD) PT Raised to $185 at Jefferies$185.00
Oct 20, 2026Bank of America SecuritiesGilead Sciences (GILD) PT Raised to $172 at BofA Securities$172.00
Oct 12, 2026Raymond JamesGilead Sciences (GILD) PT Raised to $164 at BofA Securities$164.00
Oct 8, 2026RBC CapitalGilead price target raised to $126 from $123 at RBC Capital$126.00
Oct 7, 2026Truist FinancialGilead price target raised to $158 from $150 at Truist$158.00
Sep 10, 2026HSBCGilead price target raised to $175 from $155 at HSBC$175.00
Aug 5, 2026RBC CapitalGilead price target raised to $123 from $120 at RBC Capital$123.00
Aug 5, 2026Truist FinancialGilead price target lowered to $150 from $156 at Truist$150.00